Abstract
Introduction: In patients with neurofibromatosis type 1 the prevalence of pheochromocytoma is high, the risk of having a pheochromocytoma is 10 times higher than in the general population.
Objective: Describe the case of a patient with infrequent pathologies that requires the assistance of experts for its management before and in the follow-up after surgery.
Presentation of the case: Male, 38 years old with a history of NF1, evaluated for 4 months of headache, abdominal pain and difficult-to-control arterial hypertension. A diagnosis of pheochromocytoma was made and adrenalectomy was defined with perioperative hospitalization to control blood pressure levels with alpha and beta blockers.
Discussion: The management of pheochromocytoma is surgical resection. For the surgical procedure, patients must receive alpha blockade at least 10 days before the procedure and beta blockers 3 days before. Catecholamine crises can occur intraoperatively due to mechanical stress of the tumor. when being manipulated, psychological stress and medication.
Conclusion: Surgical treatment is the choice and must be performed by an interdisciplinary group to ensure adequate control of blood pressure figures in the perioperative period and thus avoid complications.
References
Fishbein L. Pheochromocytoma/paraganglioma: is this a genetic disorder? Curr Cardiol Rep. 2019;21:104. https://doi.org/10.1007/s11886-019-1184-y
Zografos GN, Vasiliadis GK, Zagouri F, Aggeli C, Korkolis D, Vogiaki S, et al. Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends. World J Surg Oncol. 2010; 8:14. https://doi.org/10.1186/1477-7819-8-14
Vongsumran N, Kongkarnka S, Watanawittawas P, Manosroi W. Pheochromocytoma and gastrointestinal stromal tumours in an adult neurofibromatosis type 1 patient: a rare co-occurrence. BMJ Case Rep. 2020;13(6): e235129. https://doi.org/10.1136/bcr-2020-235129
Shahait A, Odisho T, Alshare B, Alghanem LJ, Weaver D. An unusual cause of adrenal mass in neurofibromatosis type 1: malignant peripheral nerve sheath tumor. Cureus. 2022; 14(1): e21782. https://doi.org/10.7759/cureus.21782
García-Agulló DO, Iriarte-Beroiz A, Rojo-Alvarado J, Munárriz P, Forga-Llenas L. Feocromocitoma familiar asociado a neurofibromatosis tipo 1. Endocrinol Nutr. 2013; 60(7):421-422.
Lee YH, Kwon MJ, Park JH, Jeong SJ, Kim TH, Jeong HW, et al. Neurofibromatosis type 1 with the development of pheochromocytoma and breast cancer. Intern Med. 2020; 59(13):1665-1669. https://doi.org/10.2169/internalmedicine.4148-19
Román-González A, Padilla-Zambrano H, Vásquez Jiménez LF. Perioperative management of pheocromocytoma/paraganglioma: a comprehensive review. Colomb J Anesthesiol. 2021; 49(3):e958. https://doi.org/10.5554/22562087.e958
Henriques-Vieira I, Almeida V, Moreno C, Paiva I. An uncommon presentation of pheochromocytoma in neurofibromatosis type 1 and the importance of long-term follow-up. Acta Med Port. 2023; 36(1):55-58. https://doi.org/10.20344/amp.16604
Theodosopoulou P, Nastos C, Paraskeva A. Anesthetic management of a patient with type 1 neuro?bromatosis and an occult pheochromocytoma: a case report. Braz J of Anesthesiol. 2023; 73(5):695-698. https://doi.org/10.1016/j.bjane.2021.02.045
Pan D, Liang P, Xiao H. Neurofibromatosis type 1 associated with pheochromocytoma and gastrointestinal stromal tumors: A case report and literature review. Oncol Lett. 2016; 12:637-643. https://doi.org/10.3892/ol.2016.4670
Bogus?awska A, Rzepka E, Opali?ska M, Sowa-Staszczak A, et al. A rare case of metastatic pheochromocytoma in the course of neurofibromatosis type 1. Pol Arch Intern Med. 2022; 132: 16291. https://doi.org/10.20452/pamw.16291
Román-González, A. Nuevos conceptos en feocromocitoma y paraganglioma en el 2017. Revista Colomb Endocrinología Diabetes Metab. 2017; 4(4): 19-23. https://doi.org/10.53853/encr.4.4.148
Zafar W, Chaucer B, Davalos F, Beenish S, Chevenon M, Nfonoyim J. Neurofibromatosis type 1 with a pheochromocytoma: A rare presentation of Von Recklinghausen disease. J Clin Endocrinol Metab. 2015; 5(5): 309-311. https://doi.org/10.14740/jem308w
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Revista Colombiana de Endocrinología, Diabetes & Metabolismo